Entry Point Capital, LLC Evolus, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 5,401 shares of EOLS stock, worth $79,448. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,401
Previous 1,889
185.92%
Holding current value
$79,448
Previous $26.4 Million
121.59%
% of portfolio
0.09%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding EOLS
# of Institutions
163Shares Held
49.1MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$84.6 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$71.3 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$43.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$42.8 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $825M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...